Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Saw Palmetto Extract May Inhibit Link to BPH - Nutraceuticals World

What are you searching for?

Sign in
Research

Saw Palmetto Extract May Inhibit Link to BPH

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

A novel saw palmetto extract (SPE), SPET-085, is as effective as finasteride, the standard prescription drug therapy, in blocking the critical enzyme that leads to benign prostatic hyperplasia (BPH), according to a study published in the July issue of Advances in Therapy.

The study, sponsored by Euromed, makers of SPET-085, evaluated the in vitro potency of SPET-085, an inhibitor of the 5α-reductase isoenzyme type II, in a cell-free test system. It revealed that SPET-085 can effectively inhibit the enzyme linked to BPH, at a lower dose as compared to hexane extracts of saw palmetto, currently regarded as the most clinically effective saw palmetto, but unavailable in the U.S.

Importantly, the study revealed that SPET-085 has bioactivity similar to finasteride, the most commonly prescribed prescription medicine for the treatment of BPH. Common finasteride side effects may include decreased sex drive, impotence or decreased ejaculate amount. For further information www.euromedusa.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters